← All stocks

Coya Therapeutics, Inc.

COYA Net buying

CIK 0001835022 #4271 in the set updated 22 Sep 2026

Bought (120 mo)

$110.01K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$110.01K

+$110.01K against sales at will

By person

9 insiders · 14 transactions

0.1×

Arun Swaminathan holds only 0.1 times base salary in stock. $71.86K of shares against $546.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Arun Swaminathan last reported holding, valued at $7.19, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Nov 2024.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Swaminathan Arun

Chief Executive Officer

$73.49K (2)

—

+$73.49K

10,000

0.0426%

$71.86K

—

Grossman Fred

Chief Medical Officer

$19.97K (1)

—

+$19.97K

2,710

0.0116%

$19.47K

—

SNYDER DAVID S

Chief Financial Officer

$12.93K (2)

—

+$12.93K

8,800

0.0375%

$63.24K

—

Lee Ann

Director

$3.62K (2)

—

+$3.62K

33,958

0.1448%

$244.02K

+106.1%

Berman Howard

Executive Chairman

— (1)

—

$0.00

10,000

0.0426%

$71.86K

—

Garren Hideki

Director

— (1)

—

$0.00

2,000

0.0085%

$14.37K

—

GOLDSTEIN DOV A MD

Director

— (1)

—

$0.00

27,557

0.1175%

$198.02K

—

Hepner Adrian

Chief Medical Officer

— (1)

—

$0.00

10,000

0.0426%

$71.86K

—

Villalobos Anabella

Director

— (1)

—

$0.00

10,000

0.0426%

$71.86K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 54

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 7

Shares from compensation/vesting 24,036

History held since 4 Jan 2023